[DPHARMA] QoQ TTM Result on 30-Sep-2013 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
19-Nov-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
30-Sep-2013 [#3]
Profit Trend
QoQ- 1.15%
YoY- 14.52%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Revenue 167,697 165,062 162,404 152,048 140,724 137,091 135,311 15.42%
PBT 39,496 42,396 40,177 40,017 39,354 35,384 35,297 7.80%
Tax -7,519 -7,243 -6,690 -9,845 -9,526 -9,378 -9,282 -13.13%
NP 31,977 35,153 33,487 30,172 29,828 26,006 26,015 14.79%
-
NP to SH 31,977 35,153 33,487 30,172 29,828 26,006 26,015 14.79%
-
Tax Rate 19.04% 17.08% 16.65% 24.60% 24.21% 26.50% 26.30% -
Total Cost 135,720 129,909 128,917 121,876 110,896 111,085 109,296 15.57%
-
Net Worth 179,145 190,050 181,818 179,017 187,404 176,143 169,359 3.82%
Dividend
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Div 24,291 24,289 24,289 20,128 20,128 19,431 19,431 16.09%
Div Payout % 75.97% 69.10% 72.53% 66.71% 67.48% 74.72% 74.69% -
Equity
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Net Worth 179,145 190,050 181,818 179,017 187,404 176,143 169,359 3.82%
NOSH 138,872 138,723 138,792 138,773 138,818 138,695 138,819 0.02%
Ratio Analysis
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
NP Margin 19.07% 21.30% 20.62% 19.84% 21.20% 18.97% 19.23% -
ROE 17.85% 18.50% 18.42% 16.85% 15.92% 14.76% 15.36% -
Per Share
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
RPS 120.76 118.99 117.01 109.57 101.37 98.84 97.47 15.39%
EPS 23.03 25.34 24.13 21.74 21.49 18.75 18.74 14.77%
DPS 17.50 17.50 17.50 14.50 14.50 14.00 14.00 16.08%
NAPS 1.29 1.37 1.31 1.29 1.35 1.27 1.22 3.80%
Adjusted Per Share Value based on latest NOSH - 138,773
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
RPS 17.43 17.16 16.88 15.81 14.63 14.25 14.07 15.39%
EPS 3.32 3.65 3.48 3.14 3.10 2.70 2.70 14.81%
DPS 2.53 2.53 2.53 2.09 2.09 2.02 2.02 16.24%
NAPS 0.1862 0.1976 0.189 0.1861 0.1948 0.1831 0.1761 3.79%
Price Multiplier on Financial Quarter End Date
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Date 30/06/14 31/03/14 31/12/13 30/09/13 28/06/13 29/03/13 31/12/12 -
Price 2.97 3.03 2.58 2.55 2.38 2.23 2.13 -
P/RPS 2.46 2.55 2.20 2.33 2.35 2.26 2.19 8.08%
P/EPS 12.90 11.96 10.69 11.73 11.08 11.89 11.37 8.80%
EY 7.75 8.36 9.35 8.53 9.03 8.41 8.80 -8.14%
DY 5.89 5.78 6.78 5.69 6.09 6.28 6.57 -7.04%
P/NAPS 2.30 2.21 1.97 1.98 1.76 1.76 1.75 20.04%
Price Multiplier on Announcement Date
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Date 26/08/14 20/05/14 26/02/14 19/11/13 28/08/13 27/05/13 25/02/13 -
Price 3.37 3.09 2.60 2.56 2.44 2.51 2.17 -
P/RPS 2.79 2.60 2.22 2.34 2.41 2.54 2.23 16.15%
P/EPS 14.64 12.19 10.78 11.77 11.36 13.39 11.58 16.97%
EY 6.83 8.20 9.28 8.49 8.81 7.47 8.64 -14.54%
DY 5.19 5.66 6.73 5.66 5.94 5.58 6.45 -13.52%
P/NAPS 2.61 2.26 1.98 1.98 1.81 1.98 1.78 29.15%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment